Diabetic Neuropathy
Increase physical activity to reduce risk for diabetic neuropathy in type 1 diabetes
Adults with type 1 diabetes for 50 years or more are less likely to have distal symmetric polyneuropathy if they performed at least 150 minutes of physical activity weekly, according to study data.
New AAN guideline details multiple options for reducing diabetic neuropathy pain
The American Academy of Neurology has updated a guideline for treating painful diabetic neuropathy using oral and topical treatments.
Age, comorbidities, medication use among predictors for severe COVID-19 in diabetes
Older age, obesity, cardiovascular disease, and pre-hospitalization use of steroids and SGLT2 inhibitors are among the factors that increase the risk for severe COVID-19 for people with diabetes, according to a speaker.
High-frequency spinal cord stimulation provides pain relief for diabetic neuropathy
An implanted 10 kHz spinal cord stimulator combined with conventional care provides better pain relief and neurologic improvement for people with painful diabetic neuropathy compared with conventional care alone, according to a speaker.
Spinal cord stimulators provide relief from diabetic neuropathic pain
An implanted 10 kHz spinal cord stimulator, when used in tandem with opioids and other pain relievers, provided patients relief from diabetic neuropathic pain, data show.
Tips for managing foot disease in diabetes during COVID-19
Foot complications of diabetes typically require face-to-face consultations and treatment, presenting several unique challenges for clinicians during the COVID-19 pandemic.
FDA approves non-opioid capsaicin pain patch for diabetic neuropathy
The FDA approved an 8% capsaicin patch for the treatment of adults with neuropathic pain associated with diabetic peripheral neuropathy of the feet, according to an industry press release.
Study shows 3D structure of damaged nerves in diabetic neuropathy
The use of three-dimensional imaging of human nerve tissue at the sub-cellular scale may help researchers better understand the pathophysiology of diabetic neuropathy, one of the most common complications of type 1 and type 2 diabetes.
Cardiovascular risks amplified by HbA1c variability in type 2 diabetes
Adults with type 2 diabetes may be at greater risk for major adverse cardiovascular events and microvascular complications if they frequently experience changes in HbA1c of 0.5% or more, according to findings presented at the European Association for the Study of Diabetes Annual Meeting.